Physician profile
Abe Green
NPI 1649462144
$9,042.17
in general payments reported to CMS, 2019-2025
44 companies · $88.99 in 2025
The $88.99 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $982 · 2021: $1,634 · 2022: $1,541 · 2023: $1,874 · 2024: $1,449 · 2025: $88.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,411.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,295.58 | 2019-2024 | Prolia, Evenity, Repatha |
| Lilly USA, LLC | $1,238.93 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $1,137.59 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $612.88 | 2019-2024 | Lokelma, Farxiga, Breztri |
| Novo Nordisk INC | $507.33 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $456.95 | 2019-2024 | Jynarque |
| Sanofi-Aventis U.S. LLC | $390.21 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.20 | 2019-2023 | Jardiance, Tradjenta, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $357.08 | 2022-2024 | |
| Mannkind Corporation | $334.28 | 2020-2024 | Afrezza |
| Mallinckrodt Hospital Products INC. | $298.56 | 2020-2024 | Acthar |
| Dexcom, INC. | $162.00 | 2019-2024 | Dexcom G6 Transmitter |
| Zealand Pharma US, INC. | $128.14 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $124.70 | 2023-2024 | |
| Ibsa Pharma INC. | $110.15 | 2019-2024 | Licart, Tirosint, Licart |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abe Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.